{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:17:43Z","timestamp":1795011463903,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.crphar.2026.100251","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:40:14Z","timestamp":1770050414000},"page":"100251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Lauve Rachel","family":"Tchokouaha Yamthe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Kengne Mediesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanick Kevin","family":"Melogmo Dongmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Raissa","family":"Matchuenkam Gayap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darline","family":"Dize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-3527","authenticated-orcid":false,"given":"Patrick Valere","family":"Tsouh Fokou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice Fekam","family":"Boyom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.crphar.2026.100251_bib1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1039\/C8MD00613J","article-title":"Rapid kill assessment of an N-arylated NH125 analogue against drug-resistant microorganisms","volume":"10","author":"Abouelhassan","year":"2019","journal-title":"MedChemComm"},{"issue":"12","key":"10.1016\/j.crphar.2026.100251_bib2","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1021\/acsinfecdis.4c00700","article-title":"Global health priority box\u2500 proactive pandemic preparedness","volume":"10","author":"Adam","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.crphar.2026.100251_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2019.01.034","article-title":"A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents","volume":"166","author":"Antoszczak","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.crphar.2026.100251_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QCO.0000000000000475","article-title":"Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden","volume":"31","author":"Baker","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.crphar.2026.100251_bib5","series-title":"Shigellosis, Hunter's Tropical Medicine and Emerging Infectious Diseases","first-page":"492","author":"Bennish","year":"2020"},{"key":"10.1016\/j.crphar.2026.100251_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fcimb.2018.00365","article-title":"Identification of anti-staphylococcal and anti-biofilm compounds by repurposing the medicines for malaria venture pathogen box","volume":"8","author":"Bhandari","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.crphar.2026.100251_bib7","article-title":"Investigating the antimicrobial potential of 560 compounds from the pandemic response box and COVID box against resistant gram-negative bacteria","volume":"13","author":"Cerqueira Melo","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.crphar.2026.100251_bib8","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, (No Title)","author":"Cockerill","year":"2012"},{"issue":"2","key":"10.1016\/j.crphar.2026.100251_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.54044\/RAMI.2022.02.01","article-title":"More on the global burden of shigellosis","volume":"81","author":"Cohen","year":"2022","journal-title":"Rom. Arch. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.crphar.2026.100251_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/acsinfecdis.4c00128","article-title":"Gyrase and topoisomerase IV: recycling old targets for new antibacterials to combat fluoroquinolone resistance","volume":"10","author":"Collins","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"9","key":"10.1016\/j.crphar.2026.100251_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. l_B","key":"10.1016\/j.crphar.2026.100251_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/26.suppl_B.7","article-title":"Usual and unusual antibacterial effects of quinolones","volume":"26","author":"Furet","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.crphar.2026.100251_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/AAC.42.5.1207","article-title":"Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods","volume":"42","author":"Klepser","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crphar.2026.100251_bib14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41467-023-36222-8","article-title":"Rapid emergence of extensively drug-resistant Shigella sonnei in France","volume":"14","author":"Lef\u00e8vre","year":"2023","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.crphar.2026.100251_bib15","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.3390\/molecules26237153","article-title":"Biological effects of quinolones: a family of broad-spectrum antimicrobial agents","volume":"26","author":"Millanao","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.crphar.2026.100251_bib16","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/ijms24032448","article-title":"Molecular mechanisms of shigella pathogenesis; recent advances","volume":"24","author":"Pakbin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.crphar.2026.100251_bib17","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.3390\/ijms24054649","article-title":"Toward a Shigella vaccine: opportunities and challenges to fight an antimicrobial-resistant pathogen","volume":"24","author":"Raso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.crphar.2026.100251_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008536","article-title":"Epidemiology of Shigella infections and diarrhea in the first two years of life using culture-independent diagnostics in 8 low-resource settings","volume":"14","author":"Rogawski McQuade","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"2","key":"10.1016\/j.crphar.2026.100251_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0023-2019","article-title":"Shigella pathogenesis: new insights through advanced methodologies","volume":"7","author":"Schnupf","year":"2019","journal-title":"Microbiol. Spectr."},{"issue":"11","key":"10.1016\/j.crphar.2026.100251_bib20","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1080\/07391102.2022.2080113","article-title":"Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box","volume":"41","author":"Sharma","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.crphar.2026.100251_bib21","series-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline","author":"Standards","year":"1999"},{"key":"10.1016\/j.crphar.2026.100251_bib22","first-page":"60","article-title":"An image-based pathogen box screen identifies new compounds with Anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery","volume":"12","author":"Tiash","year":"2020","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"12","key":"10.1016\/j.crphar.2026.100251_bib23","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1039\/C8MD00319J","article-title":"Screening of the pathogen box reveals new starting points for anti-trypanosomal drug discovery","volume":"9","author":"Veale","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.crphar.2026.100251_bib24","series-title":"WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance","year":"2024"},{"issue":"6","key":"10.1016\/j.crphar.2026.100251_bib25","first-page":"5350","article-title":"Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions","volume":"16","author":"Yuan","year":"2018","journal-title":"Exp. Ther. Med."}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257126000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257126000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:34:39Z","timestamp":1795008879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257126000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2590257126000027"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2026.100251","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2026.100251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100251"}}